327 related articles for article (PubMed ID: 32498069)
21. Mast cell chymase is a possible mediator of neurogenic bladder fibrosis.
Howard PS; Renfrow D; Schechter NM; Kucich U
Neurourol Urodyn; 2004; 23(4):374-82. PubMed ID: 15227657
[TBL] [Abstract][Full Text] [Related]
22. Regulation of rat mast cell protease 1 activity. Protease inhibition is prevented by heparin proteoglycan.
Pejler G; Berg L
Eur J Biochem; 1995 Oct; 233(1):192-9. PubMed ID: 7588746
[TBL] [Abstract][Full Text] [Related]
23. Mast cell chymase and tryptase as targets for cardiovascular and metabolic diseases.
He A; Shi GP
Curr Pharm Des; 2013; 19(6):1114-25. PubMed ID: 23016684
[TBL] [Abstract][Full Text] [Related]
24. Mast cell tissue inhibitor of metalloproteinase-1 is cleaved and inactivated extracellularly by alpha-chymase.
Frank BT; Rossall JC; Caughey GH; Fang KC
J Immunol; 2001 Feb; 166(4):2783-92. PubMed ID: 11160345
[TBL] [Abstract][Full Text] [Related]
25. The increase in tryptase- and chymase-positive mast cells is associated with partial inactivation of chymase and increase in protease inhibitors in basal cell carcinoma.
Diaconu NC; Kaminska R; Naukkarinen A; Harvima RJ; Harvima IT
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):908-15. PubMed ID: 17658999
[TBL] [Abstract][Full Text] [Related]
26. The release of histamine is associated with the inactivation of mast cell chymase during immediate allergic wheal reaction in the skin.
Saarinen JV; Harvima RJ; Naukkarinen A; Horsmanheimo M; Harvima IT
Clin Exp Allergy; 2001 Apr; 31(4):593-601. PubMed ID: 11359428
[TBL] [Abstract][Full Text] [Related]
27. Mast cell chymase inhibition reduces atherosclerotic plaque progression and improves plaque stability in ApoE-/- mice.
Bot I; Bot M; van Heiningen SH; van Santbrink PJ; Lankhuizen IM; Hartman P; Gruener S; Hilpert H; van Berkel TJ; Fingerle J; Biessen EA
Cardiovasc Res; 2011 Jan; 89(1):244-52. PubMed ID: 20693162
[TBL] [Abstract][Full Text] [Related]
28. The activation of synovial mast cells: modulation of histamine release by tryptase and chymase and their inhibitors.
He S; Gaça MD; Walls AF
Eur J Pharmacol; 2001 Feb; 412(3):223-9. PubMed ID: 11166285
[TBL] [Abstract][Full Text] [Related]
29. Decreased chymase activity is associated with increased levels of protease inhibitors in mast cells of psoriatic lesions.
Harvima IT; Haapanen L; Ackermann L; Naukkarinen A; Harvima RJ; Horsmanheimo M
Acta Derm Venereol; 1999 Mar; 79(2):98-104. PubMed ID: 10228625
[TBL] [Abstract][Full Text] [Related]
30. Biological functions of serine proteases in the granules of rat mast cells.
Katunuma N; Fukusen N; Kido H
Adv Enzyme Regul; 1986; 25():241-55. PubMed ID: 3544704
[TBL] [Abstract][Full Text] [Related]
31. Human skin chymotrypsin-like proteinase chymase. Subcellular localization to mast cell granules and interaction with heparin and other glycosaminoglycans.
Sayama S; Iozzo RV; Lazarus GS; Schechter NM
J Biol Chem; 1987 May; 262(14):6808-15. PubMed ID: 3553192
[TBL] [Abstract][Full Text] [Related]
32. Activation of paracrine TGF-beta1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase.
Lindstedt KA; Wang Y; Shiota N; Saarinen J; Hyytiäinen M; Kokkonen JO; Keski-Oja J; Kovanen PT
FASEB J; 2001 Jun; 15(8):1377-88. PubMed ID: 11387235
[TBL] [Abstract][Full Text] [Related]
33. Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase.
Caughey GH; Leidig F; Viro NF; Nadel JA
J Pharmacol Exp Ther; 1988 Jan; 244(1):133-7. PubMed ID: 2447273
[TBL] [Abstract][Full Text] [Related]
34. Human mast cell chymase induces the accumulation of neutrophils, eosinophils and other inflammatory cells in vivo.
He S; Walls AF
Br J Pharmacol; 1998 Dec; 125(7):1491-500. PubMed ID: 9884078
[TBL] [Abstract][Full Text] [Related]
35. Alterations in mast cell proteinases and protease inhibitors in the progress of cutaneous herpes zoster infection.
Kaminska R; Harvima IT; Naukkarinen A; Nilsson G; Horsmanheimo M
J Pathol; 1996 Dec; 180(4):434-40. PubMed ID: 9014866
[TBL] [Abstract][Full Text] [Related]
36. Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase.
Welle M
J Leukoc Biol; 1997 Mar; 61(3):233-45. PubMed ID: 9060446
[TBL] [Abstract][Full Text] [Related]
37. Mast cell chymase degrades the alarmins heat shock protein 70, biglycan, HMGB1, and interleukin-33 (IL-33) and limits danger-induced inflammation.
Roy A; Ganesh G; Sippola H; Bolin S; Sawesi O; Dagälv A; Schlenner SM; Feyerabend T; Rodewald HR; Kjellén L; Hellman L; Åbrink M
J Biol Chem; 2014 Jan; 289(1):237-50. PubMed ID: 24257755
[TBL] [Abstract][Full Text] [Related]
38. Tryptase in rat mast cells: properties and inhibition by various inhibitors in comparison with chymase.
Muramatu M; Itoh T; Takei M; Endo K
Biol Chem Hoppe Seyler; 1988 Jul; 369(7):617-25. PubMed ID: 3066368
[TBL] [Abstract][Full Text] [Related]
39. Extended substrate specificity of rat mast cell protease 5, a rodent alpha-chymase with elastase-like primary specificity.
Karlson U; Pejler G; Tomasini-Johansson B; Hellman L
J Biol Chem; 2003 Oct; 278(41):39625-31. PubMed ID: 12900423
[TBL] [Abstract][Full Text] [Related]
40. Mast cells in developing subepidermal bullous diseases: emphasis on tryptase, chymase and protease inhibitors.
Kaminska R; Naukkarinen A; Glinski W; Horsmanheimo M; Harvima IT
Acta Derm Venereol; 1999 Sep; 79(5):351-5. PubMed ID: 10494709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
